ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $750,000 | +118.7% | 26,000 | +141.1% | 0.42% | +23.1% |
Q3 2016 | $343,000 | -57.8% | 10,785 | -56.9% | 0.34% | -68.0% |
Q2 2016 | $812,000 | +30.1% | 25,000 | +42.9% | 1.07% | +176.7% |
Q4 2015 | $624,000 | -40.4% | 17,500 | -30.0% | 0.39% | -40.7% |
Q2 2015 | $1,047,000 | +36.7% | 25,000 | +6.4% | 0.65% | +27.4% |
Q1 2015 | $766,000 | -41.2% | 23,500 | -42.7% | 0.51% | -27.1% |
Q4 2014 | $1,302,000 | +3.1% | 41,000 | -19.6% | 0.70% | -21.5% |
Q3 2014 | $1,263,000 | -0.2% | 51,000 | -8.9% | 0.89% | +13.6% |
Q2 2014 | $1,265,000 | -24.1% | 56,000 | -18.2% | 0.79% | -12.7% |
Q1 2014 | $1,667,000 | -11.0% | 68,500 | -8.7% | 0.90% | -0.6% |
Q4 2013 | $1,874,000 | -24.2% | 75,000 | -16.7% | 0.90% | -40.1% |
Q3 2013 | $2,473,000 | +51.3% | 90,000 | 0.0% | 1.51% | +30.2% |
Q2 2013 | $1,634,000 | – | 90,000 | – | 1.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |